Using molecular diagnostic testing to personalize the treatment of patients with gastrointestinal stromal tumors.

about

Biochemical, Molecular, and Clinical Characterization of Succinate Dehydrogenase Subunit A Variants of Unknown Significance.SSAT State-of-the-Art Conference: Current Surgical Management of Gastric Tumors.

P2860

Q38671477-B70BC68E-2DA5-4917-8D57-8E78DB8600D1 Q46498642-AD335E4C-C808-4EC2-8A98-B2F79D9B01F8

P2860

Using molecular diagnostic testing to personalize the treatment of patients with gastrointestinal stromal tumors.

Item

http://www.wikidata.org/entity/Q39186932

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Using molecular diagnostic tes ...... strointestinal stromal tumors.

@en

Using molecular diagnostic tes ...... strointestinal stromal tumors.

@nl

type

Item

label

Using molecular diagnostic tes ...... strointestinal stromal tumors.

@en

Using molecular diagnostic tes ...... strointestinal stromal tumors.

@nl

prefLabel

Using molecular diagnostic tes ...... strointestinal stromal tumors.

@en

Using molecular diagnostic tes ...... strointestinal stromal tumors.

@nl

P1476

Using molecular diagnostic tes ...... astrointestinal stromal tumors

@en

P2093

Amber E Bannon

http://www.w3.org/2001/XMLSchema#string

Christopher L Corless

http://www.w3.org/2001/XMLSchema#string

Lillian R Klug

http://www.w3.org/2001/XMLSchema#string

P2860

Structural basis for activation of the receptor tyrosine kinase KIT by stem cell factor

Molecular correlates of imatinib resistance in gastrointestinal stromal tumors.

Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumors.

Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor.

PDGFRA mutations in gastrointestinal stromal tumors: frequency, spectrum and in vitro sensitivity to imatinib.

Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor

Crenolanib inhibits the drug-resistant PDGFRA D842V mutation associated with imatinib-resistant gastrointestinal stromal tumors.

Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors

Tumor risks and genotype-phenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHD.

Polyclonal nature of diffuse proliferation of interstitial cells of Cajal in patients with familial and multiple gastrointestinal stromal tumours.

P304

445-457

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14737159.2017.1308826

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Michael C. Heinrich

P577

2017-03-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28317407

http://www.w3.org/2001/XMLSchema#string

Using molecular diagnostic testing to personalize the treatment of patients with gastrointestinal stromal tumors.

about

P2860

P2860

Using molecular diagnostic testing to personalize the treatment of patients with gastrointestinal stromal tumors.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698